MMMaria Concetta La Milia

Maria Concetta La Milia

*This is an algorithmically generated author record based on publicly available information.

Maria Concetta La Milia has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Luca Tagliaferri

    UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy

    5 shared publications
  • Valentina Lancellotta

    Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Radioterapia Oncologica, Dipartimento di Diagno-stica per Immagini e Radioterapia Oncologica, Italy

    5 shared publications
  • Bruno Fionda

    Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, UOC Degenze di Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy

    4 shared publications
  • Enrico Rosa

    Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy

    4 shared publications
  • Elisa Placidi

    Department of Imaging Diagnostics, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, 00168 Rome, Italy

    3 shared publications
  • Pierpaolo Dragonetti

    UOC Degenze per la Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy

    3 shared publications

Latest Publications

  • Open Access

    Are Water-Based Algorithms Still Adequate for Dose Calculation in Modern HDR Interventional Radiotherapy? A Review with Special Focus on 3D-Printed Applicators and Heterogeneous Materials

    by Enrico Rosa, Bruno Fionda, Maria Vaccaro, Valentina Lancellotta, Elisa Placidi, Maria Concetta La Milia, Gabriele Ciasca, Pierpaolo Dragonetti, Andre Karius, Frank-André Siebert, et al.

    Background: High-dose-rate interventional radiotherapy (HDR IRT) relies on accurate dose calculations to ensure safe and effective treatment. The AAPM TG-43 formalism, based on homogeneous water assumptions, has long been the clinical standard, but the growing use of patient-specific applicators and heterogeneous materials challenges its accuracy. Materials and Methods: A literature narrative review was performed using PubMed and Scopus to identify studies comparing TG-43 and model-based dose calculation algorithms (MBDCAs), including deterministic methods (ACE, Acuros BV) and Monte Carlo simulations. Thirty-five studies were selected and qualitatively analyzed. Results: TG-43 yielded higher dose compared with MBDCAs, particularly in the presence of tissue heterogeneities, air gaps, shielding materials, and limited scatter conditions. Differences ranged from 2 to 5% in relatively homogeneous settings to more than 10–20% in complex geometries such as superficial mould treatments and head-and-neck IRT. Model-based approaches showed better agreement with Monte Carlo simulations and experimental measurements, especially in contact HDR IRT and applications involving 3D-printed applicators. Conclusion: While TG-43 remains clinically established and widely used, its limitations are increasingly evident in modern personalized HDR IRT. Model-based dose calculation algorithms provide greater dosimetric accuracy and should be progressively integrated into clinical practice, particularly in treatments involving significant heterogeneities.

  • Open Access

    Development of an Enomogram to Predict the Rate of Loco-Regional Control After Radio-Chemotherapy and Interventional Radiotherapy in Cervical Cancer

    by Valentina Lancellotta, Maria Concetta La Milia, Rosa Autorino, Enrico Rosa, Bruno Fionda, Pierpaolo Dragonetti, Leonardo Bannoni, Raffaella Michela Rinaldi, Viola De Luca, Gerardina Stimato, et al.

    Objective: This study aimed to explore the association between magnetic resonance imaging (MRI)-derived volumetric parameters and oncological outcomes, and to develop an exploratory predictive model based on these variables in patients treated with radio-chemotherapy followed by interventional radiotherapy (modern brachytherapy). Methods: Between 2021 and 2024, 300 patients with cervical cancer were included. Treatment was pelvic external beam radiotherapy with platinum-based chemotherapy followed by interventional radiotherapy boost. Volumetric MRI variables for each patient were collected. Time-to-event analyses were performed using Cox proportional hazards regression models. Model performance was assessed using Harrell’s concordance index (C-index). Internal validation was performed using bootstrap resampling. Based on the final multivariable Cox models, an interactive web-based nomogram was developed as an exploratory tool to visualize model-derived associations. Results: Median tumor volume decreased from 69.4 cm3 at diagnosis to 2.2 cm3 at the time of pre-interventional radiotherapy MRI, with a median reduction rate of 96.5%. Tumor volume at diagnosis, pre-interventional radiotherapy residual tumor volume, and tumor volume reduction rate were significantly associated with loco-regional relapse and distant metastases in Cox regression analyses. These findings were consistent across univariate and multivariable models. Internal validation confirmed the stability of the model estimates. Conclusions: MRI-derived volumetric parameters are associated with oncological outcomes in patients with locally advanced cervical cancer and may contribute to early risk stratification. The proposed model should be considered exploratory and hypothesis-generating and requires external validation before any potential clinical application.


  • Open Access

    Dosimetric Impact of Air Gaps in High-Dose-Rate Contact Interventional Radiotherapy (Modern Brachytherapy) for Non-Melanoma Skin Cancer of the Ear

    by Enrico Rosa, Bruno Fionda, Maria Vaccaro, Elisa Placidi, Valentina Lancellotta, Antonio Napolitano, Francesco Pastore, Francesca Greco, Pierpaolo Dragonetti, Maria Concetta La Milia, et al.

    Background/Objectives: The anatomical complexity of the auricular region poses a unique challenge for contact interventional radiotherapy (IRT, modern brachytherapy), especially in maintaining close conformity between the applicator and skin surface. Air gaps can arise due to the irregular shape of the ear, potentially compromising dose coverage. This study evaluates the dosimetric impact of air gaps in HDR IRT for non-melanoma skin cancer (NMSC) of the ear. Methods: Ten patients treated with contact IRT using alginate as supporting material were retrospectively analyzed. Treatment plans were recalculated using both the TG-43 and the TG-186 formalism. CTV coverage and organ-at-risk dose parameters were evaluated within the two formalisms. Results: CTV coverage was comparable between algorithms (mean V95% 96.2% vs. 94.4%, V100% 89.6% vs. 86.7%, and V150% 2.6% vs. 2.5% for TG-43 vs. TG-186; p > 0.05), while the ipsilateral eye D2cc decreased from 4.0% (TG-43) to 3.2% (TG-186). In silico simulations showed that increasing air gaps reduced skin dose progressively (up to ~15% at 5 mm), whereas alginate thickness produced only a mild dose increase (<5%) across the tested range. Overall, small air pockets (<1 mm) did not substantially alter global dosimetric metrics, although local underdosage may occur at gap locations. Conclusions: This study underscores the importance of accounting for material heterogeneities and geometric uncertainties in anatomically complex regions through advanced dose calculation algorithms.


  • Open Access

    Local radiation dose escalation in cancer treatment: Interventional radiotherapy versus modern external beam techniques

    by Maria C. La Milia, Natalia Barogi, Gyoergy Kovacs, Luca Tagliaferri, Maria A. Gambacorta, Valentina Lancellotta

    Interventional radiotherapy (IRT), also known as brachytherapy, is an advanced radiotherapeutic modality characterized by the precise placement of radioactive sources within or near the tumor. This approach enables the delivery of high radiation doses directly to the tumor site while minimizing exposure to surrounding healthy tissues. IRT is indicated for various malignancies and is integrated into both definitive and multimodal oncologic treatment strategies. Referral to IRT, as well as its implementation, often involves a multidisciplinary team including specialists from radiation oncology, surgical oncology, and medical oncology. To enhance oncological outcomes, numerous studies have investigated the incorporation of a radiotherapy boost–either IRT or external beam radiotherapy (EBRT)–targeting residual tumor following exclusive radio-chemotherapy. The decision to use an IRT boost versus an EBRT boost remains a topic of discussion and frequently depends on the equipment available at cancer centers. This systematic review aims to evaluate the comparative effectiveness of an IRT boost versus an EBRT boost in patients with breast, prostate, endometrial, cervical, head-and-neck, and anal cancers. Outcomes of interest include local control, cancer-specific survival, overall survival, distant metastasis-free survival, and treatment-related toxicity. Taking into and account, the proven clinical and economical advantages of a high-workload IRT center, education in IRT and multidisciplinary cooperation of different specialties should be forced.

  • Open Access

    PRO-NOVELTY: Patient-Reported Outcomes in NOse VEstibule interventionaL radioTherapY (brachytherapy)

    by Luca Tagliaferri, Elisabetta Sciurti, Bruno Fionda, Antonella Loperfido, Valentina Lancellotta, Elisa Placidi, Claudio Parrilla, Maria Concetta La Milia, Enrico Rosa, Mario Rigante, et al.

    Background: The aim of this paper is to evaluate the impact on the quality of life of the treatment of nasal vestibule tumors by interventional radiotherapy (IRT-brachytherapy) through a patient reported outcome questionnaire. Methods: We prospectively collected data about patients undergoing IRT according to our institutional schedule of 44 Gy delivered in 14 fractions twice a day. We recorded both acute toxicity data, using the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0, and quality of life data, using the 22-item Sino-Nasal Outcome Test (SNOT-22) at baseline (T0), at 1 month (T1), at 3 months (T3), and at 6 months (T6). Results: We enrolled 10 consecutive patients treated between February 2023 and October 2023. The decrease in terms of SNOT-22 mean value was statistically significant from T0 and T6 with a p-value < 0.001. A noteworthy clinical finding is that quality of life improved regardless of the occurrence of G1-G2 side effects. Conclusions: Using SNOT-22 on patients with nasal vestibule carcinoma treated with IRT has shown an improvement in quality of life that is not strictly dependent on the occurrence of expected G1-G2 side effects.